Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program

项目总结 巴布森生命科学创业型产品开发沉浸式创新 技术与解决方案(巴布森L-Sprint)计划 解决某些条件的商业化创新和新企业，包括 研究物质使用障碍的原因、后果和治疗的企业 (SODS)，以改善个人和公共健康，在最近的 初创企业。在学术界，商业化和科技型初创企业可能是具有挑战性的 由于报酬结构、组织结构和组织结构的不同而产生的环境 文化。许多有前途的科学家不愿追求知识产权保护。 并调查商业化机会，即使是独特的研究结果，由于缺乏 了解产品化和商业化的机制。 为了解决这些误解和挑战，同时放大潜在的影响 学术科学家可以解决SODS，巴布森生命科学企业家 新技术和解决方案的产品开发沉浸式(巴布森L-斯普林特) 该计划将接触到对产品开发和商业化感兴趣的科学家以及 培训参与者的创业思维，这也可以增加决策，改善 他们的组织和实验室来自内部，特别是在生物医学领域的产品开发 行业高度不确定。巴布森L-短跑项目包括两个目标： 目标1：课程开发--巴布森L-短跑项目将开发专门的 课程突出巴布森标志性的创业思想和行动®产品组合 提供针对市场的定制医疗保健和生物医学创业内容 细分和不确定性，将新兴技术商业化，为增长而扩展，以及 生物医学社区体验。该程序将使用现场案例、面板和其他 体验式学习技巧。 目标2：技能发展课程--我们还将制定招聘和外展计划 使用创新的全方位方法的战略，包括利用电子邮件进行直接营销， 相关会议，并通过NIH NIDA时事通讯和其他可用媒体。

PROJECT SUMMARY Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program Commercialized innovations and new ventures that address certain conditions, including ventures that address the causes, consequences, and treatment of substance use disorders (SUDs) to improve individual and public health, are still underrepresented amongst recent startups. Commercialization and technology-based start-ups can be challenging in an academic environment due to varying reward structures, organizational structures and organizational cultures. Many promising scientists are reluctant to pursue intellectual property (IP) protection and investigate commercialization opportunities, even for unique research findings, due to a lack of understanding of the mechanics towards productizing and commercialization. To address these misperceptions and challenges while amplifying the potential impact that academic scientists can make to address SUDs, the Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program will reach scientists interested in product development and commercialization as well as to train participants in entrepreneurial thinking that can also increase decision making, improve their organizations and labs from within, especially since product development in the biomedical industry is highly uncertain. The Babson L-SPRINT Program includes two aims: Aim 1: Curriculum Development--The Babson L-SPRINT program will develop a specialized curriculum highlighting Babson’s signature Entrepreneurial Thought & Action ® offering coupled with customized healthcare and biomedical entrepreneurship content on addressing market segmentation and uncertainty, commercializing emerging technologies, scaling for growth, and biomedical community experiences. The program will use live cases, panels, and other experiential learning techniques. Aim 2: Courses for Skills Development--We will also develop a recruitment and outreach strategy using an innovative omnichannel approach including direct marketing utilizing email, relevant conferences, and via NIH NIDA newsletters and other media as available.